NOVO NORDISK A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 918.50 DKK | +0.47% |
|
+4.20% | +31.57% |
| 01:57am | Eli Lilly invests $1.8 billion in Ireland sites to scale up Alzheimer's, obesity drug production | RE |
| Sep. 12 | NOVO NORDISK : Deutsche Bank keeps its Buy rating | ZD |
Main competitors
| Composite Fundamentals | Composite Valuation | Composite Consensus | Composite Momentum | Composite Visibility | Investor Rating | ESG Refinitiv | Capi. ($) | ||
|---|---|---|---|---|---|---|---|---|---|
B | 599B | ||||||||
C+ | 842B | ||||||||
C+ | 396B | ||||||||
C+ | 343B | ||||||||
B- | 292B | ||||||||
A+ | 248B | ||||||||
B+ | 244B | ||||||||
B- | 233B | ||||||||
C+ | 177B | ||||||||
C+ | 165B | ||||||||
B+ | 142B | ||||||||
B- | 104B | ||||||||
B | 97.8B | ||||||||
B | 87.38B | ||||||||
A- | 78.97B | ||||||||
A- | 67.97B | ||||||||
B+ | 47.08B | ||||||||
B | 46.2B | ||||||||
B | 40.17B | ||||||||
| Average | B | 223.79B | |||||||
| Weighted average by Cap. | B |
- Stock Market
- Equities
- NOVO B Stock
- Sector Novo Nordisk A/S
- Sector ratings